BioWorld

Aug. 12, 2003

View Archived Issues

ViroPharma Licenses CMV Drug From Glaxo For $3.5M Up Front

Read More

Traces Of Copper Up Alzheimer's Disease Plaques In Rabbits; How About Human Clinical Trials Soon?

Read More

TKT Seeking Partner Following Wyeth's Return Of Factor VIII

Read More

Curis Nets $10M Through Private Sale Of Common Stock, Warrants

Read More

Other News To Note

Read More

Renovis Raises $45M In Series E Round For Product Development

Less than a year after building its pipeline through an acquisition, Renovis Inc. raised $45 million through a Series E round of financing. (BioWorld Today) Read More